A difference between front-loaded streptokinase and standard-dose recombinant tissue-type plasminogen activator in preserving left ventricular function after acute myocardial infarction (the Central Illinois Thrombolytic Therapy Study)-Reference-Cited by-同舟云学术

A difference between front-loaded streptokinase and standard-dose recombinant tissue-type plasminogen activator in preserving left ventricular function after acute myocardial infarction (the Central Illinois Thrombolytic Therapy Study)

Published:1993-11 Issue:14 Volume:72 Page:1010-1014
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Taylor George J.,Moses H.Weston,Koester Deborah,Colliver Jerry A.,Katholi Richard E.,Dove James T.,Woodruff Robert C.,Mikell Frank L.,Becker Lewis C.,Sheehan Florence H.,Woods W.T.,Hamm David P.,Wellons Harry A.,Schneider Joel A.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference22 articles.

1. Prevention of myocardial damage in acute myocardial ischemia by early treatment with intravenous streptokinase;Koren;N Engl J Med,1985

2. Gruppo Italiano per to Studio della Streptochinasi nell'Infarto miocardico (GISSI): effectiveness of intravenous thrombolytic treatment in acute myocardial infarction;Gissi;Lancet,1986

3. Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: a comparison between intravenous tissue plasminogen activator and intravenous streptokinase;Chesebro;Circulation,1987

4. GISSI-2 and the heparin controversy;White;Lancet,1990

5. Temporal distribution of treatment to reperfusion times in patients with acute myocardial infarction receiving streptokinase or tissue plasminogen activator;Shah;J Am Call Cordial,1991

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Red Blood Cell Membrane-Coated Ultrasmall NaGdF₄ Nanoprobes for High-Resolution 3D Magnetic Resonance Angiography;ACS Applied Materials & Interfaces;2022-06-06

2. A Systematic Review and Meta-Analysis of the Safety and Effectiveness of Tenecteplase Versus Alteplase in Treatment of Patients with ST-Elevation Myocardial Infarction;Journal of Advances in Medical and Biomedical Research;2020-09-01

3. Comparative efficacy and safety of reperfusion therapy with fibrinolytic agents in patients with ST-segment elevation myocardial infarction: a systematic review and network meta-analysis;The Lancet;2017-08

4. Comparative efficacy of thrombolytics in acute myocardial infarction: a systematic review;QJM;2003-02-01

5. YM866, a Novel Modified Tissue-Type Plasminogen Activator, Affects Left Ventricular Function and Myocardial Infarct Development in Dogs With Coronary Artery Thrombi;Japanese Journal of Pharmacology;1998